Globally, both companies will become leaders in two different sectors of the pharmaceutical market
According to ISCR, clinical research will help find better and more effective treatment for rare diseases
Kyowa to exclusively market Quetiapine Fumarate extended-release tablets in Japan
Discuss challenges and growing opportunities in the pharma sector
CDSCO, US FDA, MHRA, EMA, EDQM officials share updates in regulatory guidances, identify weak spots and suggest ways to bridge these gaps
The vaccine provides protection from four influenza viruses — H1N1, H3N2, Type B (Brisbane) Drug firm Zydus Cadila has received regulatory approvals to launch tetravalent...
The seminar was attended by 95 delegates Contamination Control Society of India (CCSI), supported by Indian Society of Heating Refrigeration & Airconditioning Engrs & ASHRAE,...
MoU signed between Homoeopathic Pharmacopoeia Convention of the United States and CCRH for cooperation in the field of homoeopathic medicine
Senior managers from India and abroad hosted the celebration in the presence of more than 100 customers
Japan and South Korea are aggressively pushing for measures in the RCEP agreement that would emphasise stronger pharma corporation power at the expense of public...
The company aims to develop the best solutions to suit the business needs of clients, in compliance with international standards
The statistical design of the drug survey included as many as 224 drug molecules belonging to 15 different therapeutic categories of the NLEM 2011
MoU to be signed between Homoeopathic Pharmacopoeia Convention of the US and CCRH in the field of Homoeopathic Medicine
The production unit worth $12.5 million was inaugurated by Indian Ambassador to Egypt Sanjay Bhattacharyya
The joint funders have highlighted four priority areas – anaemia, STD, gestational diabetes mellitus, hypertensive disorders
The conference will focus on various critical challenges faced by the project managers in the pharma industry
The company has been recognised by FORTUNE as a most admired company for the third consecutive year
Priced at approx. 8100 GBP + taxes and other expenses, the programme consists of five four-day modules scheduled every eight weeks conducted at Bengaluru's Acharya...
The FDA goal date set under the Biosimilar User Fee Act (BsUFA) is October 9, 2017
Trends include ‘human factor’ principles, with ‘individualised packaging and serialisation’ as the integral solutions of the future Pharmapack Europe – organised by UBM EMEA –...
The conference will be held in Mumbai on March 16-17, 2017
The award was given for Shimadzu's state-of-the-art Mass Spectrometry technologies
A temperature-controlled and ambient goods warehouse would be set up spread on a 2.50 lakh square foot land, which would cater to pharma and life...
The net profit for the period, on a consolidated basis, was Rs 194.76 crore
Registers a net profit of Rs 1,472 crores
HOLOSTIK launches revolutionary anti-counterfeit product ‘Lenticular' to fight from fake currency at the forum
Indian Society for Clinical Research launches Causality Assessment Portal at 10th Annual Conference